Coronavirus Update: Pfizer and BioNTech launch study of omicron-specific vaccine
One day after the U.S. Food and Drug Administration said it’s halting the use of antibody drugs as COVID-19 treatments because they don’t work on the highly contagious omicron variant, Pfizer and German partner BioNTech announced they are launching a trial to evaluate an omicron-oriented vaccine in healthy adults aged 18 to 55.
On Monday, the FDA said the COVID antibody drugs from Regeneron REGN, -1.85% and Eli Lilly LLY, -1.45% should no longer be used as treatments and revoked its emergency-use authorization for both drugs. In a statement, the agency acknowledged that omicron now accounts for 99% of new cases, making it “highly unlikely” they would help people seeking treatment, as the Associated Press reported.
Hospitalizations remain above 156,000 a day but seem to be reaching a peak in many places. But deaths are still above 2,000 a day, meaning the U.S. is suffering casualties on the same scale as the terrorist attacks of Sept. 11, 2001, every two days. A New York state judge ruled Monday that the state’s face-mask mandate in public places is unconstitutional and now void, the New York Times reported, citing court documents.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Pfizer, BioNTech begin omicron-specific COVID-19 vaccine studyCOVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy adults ages 18 to 55.
Les mer »
Pfizer opens study of COVID shots updated to match omicronPfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant. Pfizer...
Les mer »
Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - studyA third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac's CoronaVac shot, a study has found.
Les mer »
Pfizer starts clinical trial for omicron-specific Covid vaccineJUST IN: Pfizer and BioNTech announce that they have started a clinical trial testing a modified Covid-19 vaccine to protect against the omicron variant.
Les mer »
Pfizer Begins Clinical Trial for Omicron-Specific COVID VaccinePfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant
Les mer »
Pfizer says it's starting clinical studies of an omicron-based COVID-19 vaccinePfizer and BioNTech said Tuesday they've stated clinical trials for an omicron-based COVID-19 vaccine.
Les mer »